Jazz Pharmaceuticals (JAZZ) Other Non Operating Income (2010 - 2026)

Jazz Pharmaceuticals' Other Non Operating Income history runs 17 years deep, the most recent figure standing at $2.5 million for Q1 2026.

• In Q1 2026, Other Non Operating Income rose 1350.0% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $145000.0 (up 102.17% YoY), while the FY2025 annual figure was -$2.6 million, up 68.61% from the prior year.
• Other Non Operating Income was $2.5 million for Q1 2026 at Jazz Pharmaceuticals, up from -$658000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $9.4 million in Q4 2023 to a low of -$10.5 million in Q1 2022.
• Historically, Other Non Operating Income has averaged -$1.1 million across 5 years, with a median of -$1.3 million in 2022.
• The sharpest annual moves came in 2022 and 2026: Other Non Operating Income slumped 1217.71% in 2022, then jumped 1350.0% in 2026.
• A 5-year view of Other Non Operating Income shows it stood at -$2.5 million in 2022, then surged by 476.83% to $9.4 million in 2023, then slumped by 167.3% to -$6.3 million in 2024, then jumped by 89.55% to -$658000.0 in 2025, then soared by 479.94% to $2.5 million in 2026.
• The last three Other Non Operating Income figures came in at $2.5 million (Q1 2026), -$658000.0 (Q4 2025), and $102000.0 (Q3 2025), per Business Quant data.